.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Argus Health
Citi
Federal Trade Commission
AstraZeneca
McKinsey
Cipla
Healthtrust
Boehringer Ingelheim
Deloitte

Generated: September 19, 2017

DrugPatentWatch Database Preview

Forest Res Inst Inc Company Profile

« Back to Dashboard

What is the competitive landscape for FOREST RES INST INC, and what generic alternatives to FOREST RES INST INC drugs are available?

FOREST RES INST INC has one approved drug.

There are two US patents protecting FOREST RES INST INC drugs.

There are sixty-two patent family members on FOREST RES INST INC drugs in thirty-five countries.

Summary for Applicant: Forest Res Inst Inc

Patents:2
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-004Sep 17, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-001Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-004Sep 17, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-002Sep 17, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-004Sep 17, 2015RXYesYes► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-003Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-001Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-002Sep 17, 2015RXYesNo► Subscribe► SubscribeYY ► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-003Sep 17, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Forest Res Inst Inc
VRAYLAR
cariprazine hydrochloride
CAPSULE;ORAL204370-001Sep 17, 2015RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Forest Res Inst Inc Drugs

Country Document Number Estimated Expiration
Portugal1663996► Subscribe
Eurasian Patent Organization200600364► Subscribe
Serbia52771► Subscribe
CroatiaP20120715► Subscribe
Hong Kong1140473► Subscribe
Montenegro00564► Subscribe
South Africa200907511► Subscribe
China101679315► Subscribe
Spain2389840► Subscribe
Malaysia148078► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Merck
Harvard Business School
Citi
Boehringer Ingelheim
Baxter
Dow
Novartis
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot